B of A Securities keeps Hims & Hers Health at "neutral" and cuts price target to $21 from $26
B of A Securities kept its "neutral" rating on Hims & Hers Health and cut its price target to $21 from $26, a 19.2% reduction. The new price target implies 31.1% upside from the November 19 close of $16.02. The four most recent analyst notes on the company over the past 30 days set price targets between $24 and $32.
In 30 seconds
- B of A Securities keeps a "neutral" rating on Hims & Hers Health.
- The price target drops to $21 from $26, a 19.2% cut.
- The new target implies 31.1% upside from the November 19 close of $16.02.
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.